This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

To investigate the safety and pharmacokinetics of S-222611

  • Research type

    Research Study

  • Full title

    A Phase I single-dose, double-blind, placebo-controlled study in healthy adult subjects to assess the safety and pharmacokinetics of S-222611



  • Sponsor organisation

    Shionogi & Co., Ltd.

  • Eudract number


  • ISRCTN Number

    No number provided

  • Identifier

    No number provided

  • Research summary

    To investigate the tolerability and safety of a range of single oral doses of S-222611 in healthy young male volunteers.

  • REC name

    London - London Bridge Research Ethics Committee

  • REC reference


  • Date of REC Opinion

    2 Feb 2009

  • REC opinion

    Favourable Opinion